• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.5 Contact Hour(s)

    Release Date

    Sunday, June 16, 2019

    Offline Date

    Tuesday, June 16, 2020

    ACPE Expiration Date

    Monday, June 6, 2022

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $0.00

    • Overview

      Chronic constipation, when broadly defined as fewer than three defecations weekly, affects about one in six Americans. The prevalence is higher in the elderly population, with some studies suggesting that 25% of individuals older than 65 have constipation.Although new-onset constipation, especially in elders, can be a sign of systemic pathology (e.g. malignancy), the overwhelming majority of those who suffer from this disorder have no discernible mucosal or structural cause and this disorder is most commonly referred to as functional constipation.  A significant segment of patients with this disorder have drug-induced constipation.Many drugs including anticholinergic drugs and calcium channel blockers may cause or contribute to constipation, but probably the most important cause of drug induced constipation is opioid induced constipation (OIC). The use of opioids for both acute and chronic pain has risen significantly in the past 20 years and accompanying this increase in opioid use has been an awareness of opioid induced bowel dysfunction.

      Handouts

      • Slide Document :   19085H01_6pp.pdf
      • Slide Document :   19085H01_2pp.pdf

      Financial Support By

      Bausch Health
    • Pharmacist

      Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.
      Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
      Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).

      Pharmacy Technician

      Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
      Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.
      Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.

      Nurse

      Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.
      Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
      Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
    • Activity Type

      Knowledge

      CE Broker

      20-660965

      Universal Activity Number

      Pharmacist 0798-0000-19-085-H01-P
      Pharmacy Technician 0798-0000-19-085-H01-T
      Nurse 0798-0000-19-085-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Geoffrey  Wall, PharmD, FCCP, BCPS
      Professor of Pharmacy Practice, Drake University, Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).